Weekender 11/21/14

Another outstanding week for New Jersey! Topping the list of good news stories, Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation, received a positive opinion for OTEZLA (apremilast) from the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use. BioNJ Member GENEWIZ, Inc. was honored by NJBIZ as the 22nd fastest growing… Read the full article

Weekender 11/14/2014

We take the trust that our Member Investors have placed in BioNJ very seriously, and we hope you will concur that our enhanced Vision. Mission and Strategic Initiatives which form the foundation of our new brand, BioNJ: The Gateway to Health, is a good use of your Investment in BioNJ. We are heartened by the… Read the full article

Weekender 11/7/14

Tuesday saw democracy in action. We offer our congratulations and thanks to all the women and men who commit their time and energies to benefiting others through public service. We look forward to working with our representatives in in our municipalities, Trenton and Washington to help propel New Jersey’s life sciences industry forward. Following the… Read the full article

Weekender 10/31/14

As you clean up the candy wrappers left at your door by this evening’s little ghosts and goblins, make sure to take some time to review the news garnered from another great week for New Jersey. And this will be another weekend when the BioNJ Team will find it hard to sleep. We have some… Read the full article

Weekender 10/24/14

It’s been quite a week for New Jersey, and for the BioNJ Team. The good news included Bridgewater-based BioNJ Member Helsinn Group and Eisai Inc. receiving Food and Drug Administration (FDA) approval AKYNZEO® and Morris Plains-based BioNJ Member Immunomedics, Inc. announcing that the European Medicines Agency (EMA) has granted orphan drug status for one of… Read the full article